what is glp 1 and gip receptor agonist GLP-1 & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) Polyagonists Enable Increasingly Effective Treatment
Description
A 2021 study revealed that individuals using a GLP-1 medication exhibited a reduction in fat-free mass when compared to those who were administered a placebo
PubMed Central, Femminella, Grazia Daniela, et al
Novo Nordisk reserves the right to modify or cancel this program at any time without notice
While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight
People with type 2 diabetes typically receive GLP-1 medications through their Medicare Part D plan rather than through the Medicare GLP-1 Bridge Program
For this reason, we did an inverse probability of censoring weighting sensitivity analysis, which yielded point estimates that were very similar to those of the primary analysis
